Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2016-12-16

New oral treatment for rheumatoid arthritis

View source ↗

Summary

The EMA announces a new oral treatment for rheumatoid arthritis, indicating regulatory approval and availability for patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications